Accrued expenses for the periods presented are comprised of the following (in thousands): | | | | | | | | | June 30, | | December 31, | | | 2026 | | 2025 | Compensation and benefits | | $ | 8,785 | | $ | 12,810 | Professional fees | | | 4,094 | | | 6,069 | Research and development | | | 3,358 | | | 3,867 | Manufacturing costs | | | 2,033 | | | 3,378 | Consulting | | | 954 | | | 1,041 | Clinical trial costs | | | 915 | | | 1,429 | Interest on Tranche 1 Notes | | | — | | | 2,710 | Other | | | 1,086 | | | 1,589 | | | $ | 21,225 | | $ | 32,893 |
|